EnBio HoldingsEnBio Holdings,Inc6092東証スタンダードサービス業FY ending Mar 2026, consolidated, J-GAAP

EnBio Holdings revenue and profit

Out of every ¥100 of sales, about ¥13 is left as operating profit. Revenue changed +18.4% from the prior year, operating profit +93.0%.

Five-year trend

Revenue¥12.6B
FY ending Mar 2022: ¥8.99B¥8.99BFY ending Mar 2023: ¥8.12B¥8.12BFY ending Mar 2024: ¥9.58B¥9.58BFY ending Mar 2025: ¥10.7B¥10.7BFY ending Mar 2026: ¥12.6B¥12.6BFY22FY23FY24FY25FY26
Operating income¥1.62B
FY ending Mar 2022: ¥1.23B¥1.23BFY ending Mar 2023: ¥1.36B¥1.36BFY ending Mar 2024: ¥815.2M¥815.2MFY ending Mar 2025: ¥839M¥839MFY ending Mar 2026: ¥1.62B¥1.62BFY22FY23FY24FY25FY26
Operating margin12.8%
FY ending Mar 2022: 13.7%13.7%FY ending Mar 2023: 16.7%16.7%FY ending Mar 2024: 8.5%8.5%FY ending Mar 2025: 7.9%7.9%FY ending Mar 2026: 12.8%12.8%FY22FY23FY24FY25FY26

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin2.1%
Asset turnover0.57×
ROA1.2%
ROA1.2%
Financial leverage2.46×
ROE3.0%

Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.

Net margin2.1%
2022: 7.3%7.3%2023: 10.0%10.0%2024: 7.4%7.4%2025: 4.2%4.2%2026: 2.1%2.1%2223242526
Asset turnover0.57×
2022: 0.55×0.55×2023: 0.48×0.48×2024: 0.52×0.52×2025: 0.53×0.53×2026: 0.57×0.57×2223242526
ROA1.2%
2022: 4.0%4.0%2023: 4.8%4.8%2024: 3.9%3.9%2025: 2.2%2.2%2026: 1.2%1.2%2223242526
Financial leverage2.46×
2022: 2.72×2.72×2023: 2.64×2.64×2024: 2.40×2.40×2025: 2.34×2.34×2026: 2.46×2.46×2223242526
ROE3.0%
2022: 10.9%10.9%2023: 12.7%12.7%2024: 9.3%9.3%2025: 5.2%5.2%2026: 3.0%3.0%2223242526
PeriodNet marginAsset turnoverROAFinancial leverageROE
20227.3%0.55×4.0%2.72×10.9%
202310.0%0.48×4.8%2.64×12.7%
20247.4%0.52×3.9%2.40×9.3%
20254.2%0.53×2.2%2.34×5.2%
20262.1%0.57×1.2%2.46×3.0%

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

PPE ÷ revenue69.4%
2021: 107.2%107.2%2022: 88.1%88.1%2023: 86.4%86.4%2024: 82.7%82.7%2025: 82.7%82.7%2026: 69.4%69.4%212223242526
PPE ÷ total assets38.4%
2021: 46.7%46.7%2022: 48.3%48.3%2023: 40.4%40.4%2024: 41.0%41.0%2025: 41.6%41.6%2026: 38.4%38.4%212223242526
Goodwill ÷ parent equity1.0%
2021: 2.3%2.3%2022: 2.0%2.0%2023: 1.6%1.6%2024: 1.2%1.2%2025: 1.1%1.1%2026: 1.0%1.0%212223242526
Goodwill balance¥86M
2021: ¥126.1M¥126.1M2022: ¥118.1M¥118.1M2023: ¥110.1M¥110.1M2024: ¥102.1M¥102.1M2025: ¥94M¥94M2026: ¥86M¥86M212223242526

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Investment and working-capital efficiency

Track R&D investment and how long operating capital remains tied up before sales turn into cash.

R&D spending¥26M
2021: ¥8.2M¥8.2M2024: ¥8.7M¥8.7M2025: ¥27.3M¥27.3M2026: ¥26M¥26M212223242526
R&D / revenue0.2%
2021: 0.1%0.1%2024: 0.1%0.1%2025: 0.3%0.3%2026: 0.2%0.2%212223242526
Receivable days—
2021: 52d52d212223242526
Inventory days181d
2021: 230d230d2022: 103d103d2023: 230d230d2024: 149d149d2025: 134d134d2026: 181d181d212223242526

R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.

Income statement (JPY millions)

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Revenue8,9888,1209,57610,66812,630
Cost of revenue6,5625,3567,0918,0148,942
Gross profit2,4262,7642,4842,6533,688
SG&A1,1971,4071,6691,8142,069
Operating income1,2291,3578158391,619
Pretax income1,0991,2331,066702915
Income tax392438326281663
Net income attributable to owners654812709452265
Operating margin13.7%16.7%8.5%7.9%12.8%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

Assets

Cash 18%
Inventories 19%
Property, plant and equipment 38%
2%
2%
Other assets 21%

Funding

Other liabilities 59%
Equity 41%
0%

Each bar totals 100% of assets; other is the residual.

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Cash and equivalents¥2.34B¥2.8B¥3.57B¥3.26B¥4.01B
Total assets¥16.4B¥17.3B¥19.3B¥21.2B¥22.8B
Net assets¥5.97B¥6.86B¥8.59B¥9.23B¥9.33B
Share capital¥1.8B¥1.8B¥2.33B¥2.33B¥2.33B
Inventories¥1.85B¥3.37B¥2.89B¥2.95B¥4.45B
Property, plant and equipment¥7.91B¥7.02B¥7.92B¥8.83B¥8.77B
Intangible assets excluding goodwill¥545.7M¥509.5M¥475.7M¥445M¥417M
Goodwill¥118.1M¥110.1M¥102.1M¥94M¥86M
Investment securities¥572.6M¥585.4M¥651.9M¥836M¥368M
Current assets¥6.46B¥7.32B¥8.25B¥8.96B¥11.4B
Current liabilities¥3.45B¥4.47B¥4.14B¥4.82B¥5.18B
Short-term borrowings¥645M¥854.4M¥1.09B¥1.79B¥972M
Long-term borrowings¥6.62B¥5.75B¥6.23B¥6.64B¥7.77B
Bonds¥36.5M————
Interest-bearing debt¥7.31Bderived————
Total liabilities¥10.4B¥10.5B¥10.7B¥12B¥13.5B
Non-controlling interests¥85.8M¥69.2M¥96.9M¥89M¥78M
Equity attributable to owners of parent¥6.01B¥6.77B¥8.48B¥8.84B¥9.04B
Retained earnings¥2.35B¥3.11B¥3.76B¥4.15B¥4.34B
Treasury stock-¥15.4M-¥15.4M-¥15.4M-¥38M-¥35M

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第27期(2025/04/01-2026/03/31)

    ID S100YKUO2026-06-25Open
  • EDINET (FSA Japan)

    有価証券報告書-第26期(2024/04/01-2025/03/31)

    ID S100W6WO2025-06-26Open
  • EDINET (FSA Japan)

    有価証券報告書-第25期(2023/04/01-2024/03/31)

    ID S100TWXI2024-06-27Open
  • EDINET (FSA Japan)

    有価証券報告書-第24期(2022/04/01-2023/03/31)

    ID S100R88U2023-06-28Open
  • EDINET (FSA Japan)

    有価証券報告書-第23期(令和3年4月1日-令和4年3月31日)

    ID S100OG4H2022-06-27Open
  • EDINET (FSA Japan)

    有価証券報告書-第22期(令和2年4月1日-令和3年3月31日)

    ID S100LRGQ2021-06-28Open

Extracted from XBRL: 53 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.